The Primary
Care Companionfor CNS Disorders

Anxiety Anxiolytics

Article April 15, 2008

Treating Depression and Anxiety in Primary Care

Prim Care Companion J Clin Psychiatry 2008;10(2):145-152

Article Abstract

Click to enlarge page

Academic highlights: Treating Depression and Anxiety in Primary Care.[CME]

View Related Activity

Go to Activity

Download Free PDF

This PDF is free for all visitors!

Save

Cite

INFORMATION FROM INDUSTRY

AUVELITY is an FDA-approved treatment for adults with MDD. Auvelity, is a rapid-acting antidepressant with a multimodal mechanism, targeting both glutamatergic and monoaminergic pathways. Learn more about how AUVELITY is thought to work and side effects. Please see Important Safety Information within this document and the full Prescribing Information.

Vol 26 • 2024 • Number 6

Read the Current Issue

Narrative Review

Dextromethorphan-Quinidine for Agitation in Dementia

Original Research

Psychiatric Comorbidities in Adolescents With Polycystic Ovary Syndrome

Original Research

Intervention to Enhance Mental Health Competency

Original Research

Evolution of Treatment Modalities for PTSD

Rounds in the General Hospital

Etiology, Prevention, and Management of TD

Rounds in the General Hospital

Comorbid Bipolar Disorder and PTSD

View current Issue

Article

Anxiety Disorders in Older Patients

January 31, 2019

Anxiety complaints are common among older adults, especially those with chronic illnesses. This narrative review describes the characteristics of common anxiety disorders among older people and provides treatment guidelines.

Raymond Pary, Simrat Kaur Sarai, Anthony Micchelli, et al

Article

Pharmacotherapy for Pediatric Anxiety Disorders: A Network Meta-Analysis

January 29, 2019

When you treat youth with anxiety disorders, are your decisions evidence-based? This meta-analysis examined efficacy and tolerability of agents studied for pediatric anxiety in double-blind, placebo-controlled trials. Read the...

Eric T. Dobson, Michael H. Bloch, Jeffrey R. Strawn

Article

Mindfulness-Based Stress Reduction for Older Adults

August 23, 2017

Stress and stress-related disorders such as depression and anxiety can accelerate neurocognitive aging. Could a mindfulness intervention be a way to enhance memory and clinical outcomes in older patients?...

Julie Loebach Wetherell, Tamara Hershey, Steven Hickman, et al

Treating Depression and Anxiety in Primary Care

Read the Current Issue

Dextromethorphan-Quinidine for Agitation in Dementia

Psychiatric Comorbidities in Adolescents With Polycystic Ovary Syndrome

Intervention to Enhance Mental Health Competency

Evolution of Treatment Modalities for PTSD

Etiology, Prevention, and Management of TD

Comorbid Bipolar Disorder and PTSD

ELSEWHERE:

FOLLOW US:

Treating Depression and Anxiety in Primary Care

Read the Current Issue

Dextromethorphan-Quinidine for Agitation in Dementia

Psychiatric Comorbidities in Adolescents With Polycystic Ovary Syndrome

Intervention to Enhance Mental Health Competency

Evolution of Treatment Modalities for PTSD

Etiology, Prevention, and Management of TD

Comorbid Bipolar Disorder and PTSD

Related Articles

Anxiety Disorders in Older Patients

Pharmacotherapy for Pediatric Anxiety Disorders: A Network Meta-Analysis

Mindfulness-Based Stress Reduction for Older Adults

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles